Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oral bacteria glycolytic enzymes are a group of enzymes that catalyze the breakdown of carbohydrates (primarily sugars) into energy through the glycolysis pathway. This process is central to the metabolism of many oral bacteria, especially those implicated in dental caries, such as *Streptococcus mutans* and *Lactobacillus* species. The glycolytic pathway enables these bacteria to convert dietary sugars into organic acids (mainly lactic acid), which can demineralize tooth enamel and contribute to cavity formation. Key enzymes include enolase, phosphoglycerate kinase (PGK), and glyceraldehyde 3-phosphate dehydrogenase. Fluoride acts as a potent inhibitor of enolase, leading to reduced acid production. Targeting these enzymes has therapeutic implications for preventing dental caries.
Enzyme inhibition
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oral Bacteria Glycolytic Enzymes.